levofloxacin / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   137 Trials   137 Trials   5343 News 


«12...79808182838485868788899091»
  • ||||||||||  nitazoxanide / Generic mfg.
    Trial primary completion date:  A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) -  Jan 3, 2018   
    P3,  N=100, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2017 --> Dec 2022
  • ||||||||||  Dexilant (dexlansoprazole) / Takeda
    Trial primary completion date:  Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori (clinicaltrials.gov) -  Nov 27, 2017   
    P4,  N=180, Recruiting, 
    Trial primary completion date: Dec 2017 --> Dec 2022 Trial primary completion date: Jul 2017 --> Dec 2017
  • ||||||||||  levofloxacin / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date, Surgery:  Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery (clinicaltrials.gov) -  Oct 12, 2017   
    P3,  N=576, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Completed | N=430 --> 576 | Trial primary completion date: Sep 2016 --> Mar 2017
  • ||||||||||  Trial primary completion date:  Personalized Treatment for Refractory H Pylori Infection (clinicaltrials.gov) -  Sep 29, 2017   
    P=N/A,  N=150, Recruiting, 
    Trial primary completion date: Jun 2019 --> Mar 2018 Trial primary completion date: Dec 2016 --> Dec 2018
  • ||||||||||  levofloxacin / Generic mfg.
    Trial completion, Combination therapy:  Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) -  Jul 28, 2017   
    P2,  N=111, Completed, 
    Not yet recruiting --> Enrolling by invitation Active, not recruiting --> Completed
  • ||||||||||  levofloxacin / Generic mfg., prulifloxacin / Generic mfg.
    New P2 trial:  Prulifloxacin in Chronic Bacterial Prostatitis (CBP) (clinicaltrials.gov) -  Jun 27, 2017   
    P2,  N=148, Recruiting, 
  • ||||||||||  clarithromycin / Generic mfg.
    Enrollment open:  Hepys (clinicaltrials.gov) -  Jun 20, 2017   
    P=N/A,  N=2500, Recruiting, 
    Trial primary completion date: Jun 2017 --> Dec 2017 Not yet recruiting --> Recruiting
  • ||||||||||  levofloxacin / Generic mfg.
    Trial primary completion date:  RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis (clinicaltrials.gov) -  May 24, 2017   
    P=N/A,  N=82, Recruiting, 
    Trial primary completion date: Mar 2017 --> Mar 2019 Trial primary completion date: Dec 2016 --> Dec 2017
  • ||||||||||  levofloxacin / Generic mfg., itraconazole / Generic mfg., voriconazole / Generic mfg.
    New trial:  UVX as an Adjuvant in the Treatment of Fungal Keratitis (clinicaltrials.gov) -  May 3, 2017   
    P=N/A,  N=20, Active, not recruiting, 
  • ||||||||||  AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
    Enrollment closed:  Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) -  Apr 29, 2017   
    P=N/A,  N=20, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  ceftriaxone / Generic mfg., levofloxacin / Generic mfg.
    Enrollment open:  Antibiotics to Decrease Post ERCP Cholangitis (clinicaltrials.gov) -  Apr 20, 2017   
    P4,  N=200, Recruiting, 
    Initiation date: Apr 2016 --> Apr 2017 Not yet recruiting --> Recruiting
  • ||||||||||  AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
    New trial:  Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) -  Mar 31, 2017   
    P=N/A,  N=20, Recruiting, 
  • ||||||||||  ceftriaxone / Generic mfg., levofloxacin / Generic mfg.
    New P4 trial:  Antibiotics to Decrease Post ERCP Cholangitis (clinicaltrials.gov) -  Mar 22, 2017   
    P4,  N=200, Not yet recruiting, 
  • ||||||||||  levofloxacin / Generic mfg.
    Trial primary completion date, Combination therapy:  Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) -  Mar 1, 2017   
    P2,  N=111, Active, not recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Mar 2017 --> Jul 2017
  • ||||||||||  levofloxacin / Generic mfg., rifampicin / Generic mfg.
    Enrollment open:  TBM-KIDS: Optimizing Treatment to Improve TBM Outcomes in Children (clinicaltrials.gov) -  Feb 27, 2017   
    P1/2,  N=120, Recruiting, 
    Trial primary completion date: Mar 2017 --> Jul 2017 Not yet recruiting --> Recruiting
  • ||||||||||  levofloxacin / Generic mfg., fluconazole oral / Generic mfg., itraconazole / Generic mfg.
    Clinical:  Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients (clinicaltrials.gov) -  Feb 17, 2017   
    P=N/A,  N=1000, Recruiting, 
    Initiation date: Dec 2016 --> Feb 2016 | Trial primary completion date: Mar 2017 --> Jul 2017 | Not yet recruiting --> Recruiting Trial primary completion date: Nov 2016 --> Nov 2017